BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12766088)

  • 1. Dose-dependent modulation of choroidal neovascularization by plasminogen activator inhibitor type I: implications for clinical trials.
    Lambert V; Munaut C; Carmeliet P; Gerard RD; Declerck PJ; Gils A; Claes C; Foidart JM; Noël A; Rakic JM
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2791-7. PubMed ID: 12766088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization.
    Lambert V; Munaut C; Noël A; Frankenne F; Bajou K; Gerard R; Carmeliet P; Defresne MP; Foidart JM; Rakic JM
    FASEB J; 2001 Apr; 15(6):1021-7. PubMed ID: 11292663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mice without uPA, tPA, or plasminogen genes are resistant to experimental choroidal neovascularization.
    Rakic JM; Lambert V; Munaut C; Bajou K; Peyrollier K; Alvarez-Gonzalez ML; Carmeliet P; Foidart JM; Noël A
    Invest Ophthalmol Vis Sci; 2003 Apr; 44(4):1732-9. PubMed ID: 12657615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of choroidal neovascularization by a peptide inhibitor of the urokinase plasminogen activator and receptor system in a mouse model.
    Das A; Boyd N; Jones TR; Talarico N; McGuire PG
    Arch Ophthalmol; 2004 Dec; 122(12):1844-9. PubMed ID: 15596589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pharmacologic plasminogen activator inhibitor-1 inhibition on cell motility and tumor angiogenesis.
    Leik CE; Su EJ; Nambi P; Crandall DL; Lawrence DA
    J Thromb Haemost; 2006 Dec; 4(12):2710-5. PubMed ID: 17010152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent.
    Devy L; Blacher S; Grignet-Debrus C; Bajou K; Masson V; Gerard RD; Gils A; Carmeliet G; Carmeliet P; Declerck PJ; Nöel A; Foidart JM
    FASEB J; 2002 Feb; 16(2):147-54. PubMed ID: 11818362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization.
    Rakic JM; Lambert V; Devy L; Luttun A; Carmeliet P; Claes C; Nguyen L; Foidart JM; Noël A; Munaut C
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3186-93. PubMed ID: 12824270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of glioma cell invasion and motility by adenoviral gene transfer of PAI-1.
    Hjortland GO; Bjørnland K; Pettersen S; Garman-Vik SS; Emilsen E; Nesland JM; Fodstad O; Engebraaten O
    Clin Exp Metastasis; 2003; 20(4):301-9. PubMed ID: 12856717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumoral and choroidal vascularization: differential cellular mechanisms involving plasminogen activator inhibitor type I.
    Jost M; Maillard C; Lecomte J; Lambert V; Tjwa M; Blaise P; Alvarez Gonzalez ML; Bajou K; Blacher S; Motte P; Humblet C; Defresne MP; Thiry M; Frankenne F; Gothot A; Carmeliet P; Rakic JM; Foidart JM; Noël A
    Am J Pathol; 2007 Oct; 171(4):1369-80. PubMed ID: 17717143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of hyaluronan and its receptor CD44 with choroidal neovascularization.
    Mochimaru H; Takahashi E; Tsukamoto N; Miyazaki J; Yaguchi T; Koto T; Kurihara T; Noda K; Ozawa Y; Ishimoto T; Kawakami Y; Tanihara H; Saya H; Ishida S; Tsubota K
    Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4410-5. PubMed ID: 19339747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor-1 mRNA expression in cultured pigmented ciliary epithelial cells of the porcine eye.
    Meyer MW; von Depka M; Wilhelm C; Schröder A; Erb C
    Graefes Arch Clin Exp Ophthalmol; 2002 Aug; 240(8):679-86. PubMed ID: 12192463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor type-1 mutants regulate angiogenesis of human umbilical and lung vascular endothelial cells.
    Chorostowska-Wynimko J; Swiercz R; Skrzypczak-Jankun E; Selman SH; Jankun J
    Oncol Rep; 2004 Dec; 12(6):1155-62. PubMed ID: 15547731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laser-induced choroidal neovascularization in mice attenuated by deficiency in the apelin-APJ system.
    Hara C; Kasai A; Gomi F; Satooka T; Sakimoto S; Nakai K; Yoshioka Y; Yamamuro A; Maeda S; Nishida K
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4321-9. PubMed ID: 23722395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
    Kim KL; Suh W
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
    Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dioxin on vascular endothelial growth factor (VEGF) production in the retina associated with choroidal neovascularization.
    Takeuchi A; Takeuchi M; Oikawa K; Sonoda KH; Usui Y; Okunuki Y; Takeda A; Oshima Y; Yoshida K; Usui M; Goto H; Kuroda M
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3410-6. PubMed ID: 19182260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Urokinase Receptor-Derived Peptide UPARANT Mitigates Angiogenesis in a Mouse Model of Laser-Induced Choroidal Neovascularization.
    Cammalleri M; Dal Monte M; Locri F; Lista L; Aronsson M; Kvanta A; Rusciano D; De Rosa M; Pavone V; André H; Bagnoli P
    Invest Ophthalmol Vis Sci; 2016 May; 57(6):2600–2611. PubMed ID: 27168367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation.
    Ji Y; Weng Z; Fish P; Goyal N; Luo M; Myears SP; Strawn TL; Chandrasekar B; Wu J; Fay WP
    Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2167-2175. PubMed ID: 27659097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of statins on modulation by insulin of expression of plasminogen activator inhibitor type-1.
    Sato Y; Dong J; Imagawa S; Ishimori N; Furumoto T; Tsutsui H; Sobel BE; Fujii S
    Coron Artery Dis; 2008 Aug; 19(5):355-61. PubMed ID: 18607173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.